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1. Introduction 
Polycyclic aromatic hydrocarbons such as benzo- 
[alpyrene (BP) exert their toxic effects after meta- 
bolic activation. A delicate balance between activating 
and detoxifying enzyme reactions may be decisive for 
the accumulation of reactive intermediates in cells 
and may explain in part the organ specificity of toxic 
effects. UDP-glucuronosyltransferase (CT, EC 2.4. 
1.17) is one of the enzymes conjugating intermediary 
phenols and dihydrodiols of BP [l-3], thus prevent- 
ing direct cytotoxicity of these intermediates and 
recycling to ultimate cytotoxins, mutagens, and car- 
cinogens [4]. BP quinones, a third major class of 
primary metabolites, can be readily conjugated with 
glucuronic acid after reduction to their quinols [5,6]. 
BP quinones may cause cytotoxicity in many ways, 
for example, after reduction to semiquinones or by 
oxidation-reduction cycles with continuous produc- 
tion of HzOz, 0, and OH’ [7]. In addition quinones 
strongly inhibit BP oxidation [6]. When inhibitory 
quinones are removed by stimulation of conjugation 
of the corresponding quinols, BP monooxygenase 
activity is increased [6,8]. 
CT probably consists of a family of closely related 
but functionally heterogeneous enzyme forms. Two 
forms are differentially inducible in rat liver by 
inducing agents such as 3-methylcholanthrene (MC) 
or phenobarbital [9,10]. They can be separated and 
purified to apparent homogeneity [ 1 l] and show 
different developmental patterns [ 121 and tissue dis- 
tributions [3]. The methylcholanthrene-inducible 
form of GT is operationally called GT1 [3]. All 
enzyme forms are latent in the intact microsomal 
membrane. They can be activated by UDP-N-acetyl- 
glucosamine, which is probably a physiological acti- 
vator, and can be fully activated by various alterations 
of the membrane structure, e.g., by the addition of 
detergents [ 131. To be able to distinguish induction 
from activation, enzyme induction is usually studied 
in the fully activated state. 
Because of the complexity of GT activities it was 
necessary to investigate which form of GT is respon- 
sible for the conjugation of BP quinols. We demon- 
strate that isolated GT1 and NADPH-cytochrome c 
reductase from rat liver, both purified to apparent 
homogeneity, readily form BP-3,6-quinol glucuronides 
from BP-3,6-quinone. Using a sensitive fluorimetric 
assay for the detection of BP-3,6quinol glucuronides, 
rates of conversion obtained with the purified 
enzymes are compared with those determined with 
the membrane-bound enzymes from liver microsomes. 
2. Materials and methods 
Previously described methods were used for treat- 
ment of rats in vivo with MC or phenobarbital, for 
preparation of liver microsomes, for assay of GT activ- 
ity with I-naphthol as substrate [ 141, and for purifi- 
cation of CT1 to apparent homogeneity [Ill. The GT 
preparation may be similar to that in [ 151. Purified 
GT1 (6000 mU/mg protein) was stored at 4’C after 
addition of egg lecithin dispersions (0.1 mg/ml enzyme 
solution). Under these conditions the enzyme was 
stable for 4 weeks with 25% loss of enzyme activity. 
NADPH-cytochrome c reductase was isolated from 
trypsin-treated microsomes and purified according to 
[16] to spec. act. 4000 mU/mg protein. One unit is 
the enzyme activity which metabolizes 1 pmol sub- 
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strate/min at 37°C (25’C for NADPH-cytochrome c 
reductase). 
Conversion of BP-3,6quinone to its quinol glucu- 
ronides: BP-3,6-quinone was dissolved in hexamethyl- 
phosphoramide and incubated at 0.05 mM with fresh 
liver microsomes (O-.2 mg protein) or purified enzymes 
(amounts specified in table l), Tris-HCl (pH 7.4) 
(0.1 M), MgClz (5 mM), NADP (0.5 mM), sodium iso- 
citrate (5 mM), isocitrate dehydrogenase (100 mu; 
Boehringer, Mannheim), and UDP-glucuronic acid 
(3 mM) in 0.5 ml. Activators of the microsomal 
enzyme (Brij 58,0.05% (v/v) or UDP-N-acetylglucos- 
amine, 3 mM) were added when indicated. At 0,5, 10 
and 20 min 0.1 ml aliquots were taken from the incu- 
bation mixture. Unmetabolized quinone and quinol 
were extracted with 1 ml CHCla. After addition of 
0.1 ml methanol and 1 .O ml 0.4 M glycine buffer 
(pH 10) to 0.05 ml of the aqueous phase, fluorescence 
of the quinol glucuronides was determined. 
Fluorescence was detected at 433 nm with excita- 
tion at 400 nm using a Perkin-Elmer 650-10 S fluo- 
rescence spectr’ophotometer (fig. 1). Interference in 
the fluorescence spectrum by BP-3,6-quinol at pH 10 
(obtained by addition of sodium dithionite to a BP- 
3,6-quinone solution) is not possible since the quinol 
spectrum is quite different (maxima of excitation and 
emission at 430 nm and 535 nm, respectively). Zero 
time blanks were subtracted. The fluorescence was 
quantified in a parallel incubation using [ 14C] BP-3,6- 
quinone prepared by enzymatic conversion of [7,10- 
r4C] BP (Amersham) followed by isolation of [ 14C] BP- 
3,6-quinone by HPLC [ 171. The HPLC gave a clean 
separation of BP-3,6-quinone from BP-1,6-quinone. 
Conversion rates increased linearly up to 0.2 mg 
microsomal protein and up to 20 min. No change of 
the fluorescence spectrum was observed during 2 h 
incubation and after storage of the incubation mix- 
ture overnight at 0°C. It remains to be established at 
which position of the benzo [a] pyrene ring (3-, 6- or 
both) the glucuronic acid moiety is attached. 
3. Results and discussion 
With rat liver microsomes BP-3,6-quinone could be 
converted to its quinol glucuronides to the extent of 
75-98% (fig.2, I). Addition of purified NADPH-cyto- 
chrome c reductase to microsomes enhanced the con- 
version rate with microsomes, whether activated by 
detergent (cf. b with a) or by UDP-N-acetylglucos- 
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Fig.1. Fluorescence spectrum of benzo [alpyrene-3,6quinol 
glucuronides. The fluorescence spectrum of quinol glucu- 
ronides in the water/methanol phase at pH IO was recorded 
as in section 2. The excitation spectrum was recorded at 
433 nm emission wavelength, the emission spectrum at 
400 nm excitation wavelength. 
amine (cf. d with c). The metabolic pathway is unusual 
since the intermediary quinol is rapidly autoxidized 
in the presence of oxygen [7]. Hence the steady state 
concentration of the quinol should be rather low. 
Since NADPH-cytochrome c reductase was isolated 
from trypsin-treated microsomes it had lost the hydro- 
phobic protein segment which is essential for attach- 
ment to the microsomal membrane [ 181. Nevertheless 
quinol generated by the soluble reductase could be 
readily conjugated by the membrane-bound GT. Con- 
version of the quinone to its quinol glucuronides could 
also be demonstrated with isolated GTr and NADPH- 
cytochrome c reductase, purified to apparent homo- 
geneity (fig.2, II; table 1). The reaction was linear for 
a remarkably long time period. Decreasing the quantity 
of reductase only slightly affected glucuronide forma- 
tion; increasing GT, proportionally enhanced it. 
Hence GT activity appeared to be the major deter- 
minant of the overall conversion rate. 
In addition to NADPH-cytochrome c (P450) reduc- 
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Fig.2. Time course of the conversion of benzo[a]pyrene-3,6quinone to its glucuronides with rat liver microsomes (I) or purified 
NADPH-cytochrome c reductase and UDP-glucuronosyltransferase (II). Microsomes from MC-treated rats, activated by Brij 58 
(a,b) or UDP-Nacetylglucosamine (c,d), were incubated with benzo[a]pyrene-3,6quinone (20 MM). In b and d, purified NADPH- 
cytochrome c reductase (700 mu) was also present. The initial amount of benzo[a]pyrene-3,6quinone present in the incubation 
mixture is indicated by the dashed line. In II, purified NADPH-cytochrome c reductase and GT, (amounts specified in table 1) 
were incubated with 50 ILM benzo[a]pyrene-3,6quinone (a); in (b) the quantity of the reductase was reduced to l/5, and in (c) 
the amount of CT was increased 2.5fold. 
tase (EC 1.6.2.4) liver microsomes (and cytosol) con- 
tain another quinone reductase, DT diaphorase (19, 
EC 1.6.99.2). In contrast to NADPH-cytochrome c 
reductase (inducible by phenobarbital), DT diaphor- 
ase, like CT,, is preferentially inducible by MC [20]. 
Hence the quantities of the two reductases and of 
GT, can be markedly altered by treatment with 
inducing agents. Bates of conversion of BP-3,6- 
quinone to its quinol glucuronides are correlated with, 
but not proportional to, CT, activity after treatment 
with inducers and activators of GT (table 1). The con- 
version rate found with microsomes from MC-treated 
rats was over-proportionally increased, suggesting that 
not only CT, but also DTdiaphorase may be involved 
in the stimulated conversion. The significance and 
mechanism of GT activation is still under debate [ 131. 
Our results demonstrate that GT,, the MC-inducible 
form of GT, is mainly responsible for the conjugation 
of BP-3,6-quinol and probably other BP quinols. The 
activity of GT2 towards BP-3,6-quinol has not yet 
been tested. MC-inducible enzymes such as BP mono- 
oxygenase, DT diaphorase, and GTr are metabolically 
coordinated in the formation and further metabolism 
of BP quinones. As shown with inbred strains of mice, 
MC-inducibility of these three enzymes is inherited 
as a single genetic trait [21,22]. Coordinated induc- 
tion of these enzymes may facilitate BP detoxication 
and elimination. It remains to be shown, however, to 
what extents these enzyme reactions occur under in 
vivo conditions. 
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Table 1 
Initial rates of conversion of benzo[a]pyrene-3,6quinone to its glucuronides under various conditons 
_~ 
Exper~ental Conversion of BP-3,6- CT, activity NADPH~ytochrome c 
conditions quinone to its quinol towards I-naphthoi reductase 
glucuronides 
Microsomes (mUjmg protein) 
Untreated controls: 
Native 0.009 r 0.001 2.4 t 0.6 40+ 3 
+ UDP-N-acetylglucosamine 0.014 + 0.001 7.9 f 1.3 
+ Brij 58 0.039 * 0.003 61 f 15 
Phenobarbit~-tr~tment: 
Native 0.013 t 0.003 3.6 + 0.9 94 f 20 
+ UDP-Nacetylglucosamine 0.020 + 0.005 9.4 * 3.6 
+ BrQ 58 0.063 * 0.015 85 + 20 
MC-treatment: 
Native 0.26 ?: 0.10 8.1 r 2.0 49* 3 
+ UDP-Nacetylglucosamine 0.43 + 0.10 14.6 + 3.1 
+ Brij 58 2.00 + 0.21 249 +46 
NADPH~ytochrome c (mU/ml) 
reductase + CT,: 
Complete 0.04 11.8 181 
Reductase, 1 I.5 0.03 11.8 36 
GT, ,2 .S;fold 0.10 29.7 181 
GT, activity towards I-naphthol and NADPH-cytochrome c reductase activity are given for comparison. The 
experiment with the purified enzymes was repeated once with similar results. The mean * SD of 4 expt with 
microsomes is listed 
Acknowledgements 
We thank Miss S. Zachmann and Miss U. Heine for 
expert technical assistance and Dr R. F. Volp for help 
in preparing the English manuscript. Supply of benzo- 
[alpyrene-3,6-quinone by the ITT Research Institute 
(Chicago, IL) and financial support by the Stiftung 
Volkswagenwerk are gratefully acknowledged. 
References 
[ 11 Nemoto, N. and Gelboin, H. V. (1976) Biochem. Phar- 
PI 
[31 
[41 
[51 
161 
272 
macol. 25,1221-1226. 
Bock, K. W. and LBienblum. W. (1979) Biochem. Phar- 
macol. 28,695-700. 
Bock, K. W., Clausbruch, U. C. v., Kaufmann, R., 
Lilienblum, W., Oesch, I;., Pfeil, H. and Platt, K. L. 
(1980) Biochem. Pharmacol. 29,495-500. 
Sims, P., Grover, P. L., Swaisiand, A., Pal, K, and 
Hewer, A. (1974) Nature 252, 326-328. 
Lind, C., Vadi, H. and Emster, L. (1978) Arch. Bio- 
them. Biophys. 190,97-108. 
Fahl, W. E.. Shen, A. L. and Jefcoate, C. R. (1978) 
Biochem. Biophys. Res. Commun. 85,891-899. 
[7] Lorentzen, R. J. and Ts’o, P. 0. P. (1977) Biochemistry 
16,1467-1473. 
[ 81 Bock, K. W. (1978) Na~yn-Schmiedeberg,s Arch. Phar- 
macol. 304,77-79. 
[P] Bock, K. W., FrShling, W., Remmer, H. and Rexer, B. 
(1973) Biochim. Biophys. Acta 327,46-56. 
[lo] Wishart, G. J. (1978) Biochem. J. 174,671-672. 
[ 111 Bock, K. W., Josting, I)., Li~enblum. W. and Pfeil, H. 
(1979) Eur. J. Biochem. 98,19-26. 
[12] Wishart, G. .I. (1978) Biochem. J. 174,485-489. 
1131 Dutton, G. J. (1975) Biochem. Pharmacol, 24, 
1835-1841. 
[14] Bock,K.W.and White, I. N. H. (1974) Eur. J. Biochem. 
46,451-459. 
[15] Burchell, B. (1978) Biochem. J. 173,749-757. 
[ 161 Omura, T., Siekevitz,P. and Palade, G. E. (1967) J. Biol. 
Chem. 242,2389-2396. 
[ 171 Selkirk, J. K., Croy, R. G., Roller, P. P., Gelboin, H. V. 
(1974) Cancer Res. 34,3473-3480. 
[18] Ito, A. and Sato, R. (1969) J. Cell, Biol. 40,179-189. 
[19] Ernster, L., Danielson, L. and Ljunggren, M. (1962) 
Biochim. Biophys. Acta 58,171-188. 
[20] Lind, C. and Ernster, L. (1974) Biochem. Biophys. Res. 
Commun. 56,392-400. 
[21] Owens, I. S. (1977) J. Biol. Chem. 252,2827-2833. 
[22] Kumaki, K., Jensen, N. M., Shire, J. G. M. and Nebert, 
D. W. (1977) J. Biol. Chem. 252,157-165. 
